VXRT

5.34% -0.0338

Handel nachbörslich: .60 0.0013 +0.22%

Vaxart Inc (VXRT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Vaxart Inc Stock (VXRT) Company Profile

Healthcare (1100)

Biotechnology (613)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

VXRT's Discussions on Twitter

Compare VXRT vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VXRT Vaxart Inc	0.5987	0	237.26M	16.33M	7.57M	0.0593
VRTX Vertex Pharmaceuticals Inc	442.96	113.41B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	611.34	66.62B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	882.41	55.43B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	292.16	40.46B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	148.49	31.73B	742.00K	-1.37B	-1.07B	-7.0731

Vaxart Inc Stock (VXRT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-08-15	Eingeleitet	Oppenheimer	Outperform
2021-12-29	Fortgesetzt	Jefferies	Buy
2021-11-02	Eingeleitet	Cantor Fitzgerald	Overweight
2021-06-29	Herabstufung	B. Riley Securities	Buy → Neutral
2021-06-24	Eingeleitet	Jefferies	Buy
2021-06-11	Eingeleitet	Piper Sandler	Overweight
2020-08-12	Bestätigt	H.C. Wainwright	Buy
2020-07-13	Eingeleitet	B. Riley FBR	Buy

Alle ansehen

Vaxart Inc Aktie (VXRT) Neueste Nachrichten

Finanzdaten der Vaxart Inc-Aktie (VXRT)

Vaxart Inc (VXRT)

Vaxart Inc Stock (VXRT) Company Profile

Compare VXRT vs VRTX, REGN, ARGX, ALNY, RVMD

Vaxart Inc Stock (VXRT) Upgrades & Downgrades

Vaxart Inc Aktie (VXRT) Neueste Nachrichten

[DFAN14A] Vaxart, Inc. SEC Filing - Stock Titan

Vaxart Mails a Letter to Shareholders - marketscreener.com

Vaxart Urges Shareholders to Vote “FOR” ALL Six of the Company’s Highly Qualified Director Nominees on the WHITE Proxy Card TODAY - Yahoo Finance

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Vaxart (VXRT) Investors of Securities Fraud Class Action and Encourages Investors with Significant Losses to Contact the Firm, Application Deadline Approaching - TMX Newsfile

Vaxart Files Definitive Proxy Statement and Mails Letter to Shareholders - The Manila Times

Vaxart Shareholder Alert - TMX Newsfile

Vaxart (NASDAQ: VXRT) Board rebuffs activist slate in contested proxy - Stock Titan

Vaxart director Mark Watson buys $6,530 in company stock By Investing.com - Investing.com South Africa

Vaxart director Mark Watson buys $6,530 in company stock - Investing.com UK

Vaxart, Inc. (VXRT) director adds 10,000 shares in open‑market buy - Stock Titan

Vaxart | 4: Statement of changes in beneficial ownership of securities-Officer Lo Steven - Moomoo

Daniel P. Houle Solicits Proxies from Shareholders of Vaxart - marketscreener.com

Activist group (VXRT) with 1.52M shares seeks majority on Vaxart board via GOLD proxy - Stock Titan

Vaxart (NASDAQ: VXRT) CFO uses 31,395 shares to cover RSU taxes - Stock Titan

Vaxart faces proxy contest ahead of July annual meeting By Investing.com - Investing.com Australia

Vaxart, Inc Provides Information to the Shareholders - marketscreener.com

Vaxart Emphasizes Board Stability and Oral Vaccine Platform Progress Ahead of 2026 Shareholder Vote - Minichart

Vaxart faces proxy contest ahead of July annual meeting - Investing.com UK

Vaxart Urges Shareholder Support Amid Proxy Contest, Updates Pipeline - TipRanks

VXRT: Oral pill vaccine platform advances with strong clinical data and extended financial runway - TradingView

Vaxart (NASDAQ: VXRT) proxy fight — Board backs six nominees, urges WHITE card - Stock Titan

Vaxart files preliminary proxy, urges support for board as Phase 2b COVID readout, $61M cash runway into Q2 2027 - TradingView

Vaxart (VXRT) readies contested 2026 vote as trial advances and runway extends to 2027 - Stock Titan

Vaxart (VXRT) registers 32.9M shares; up to $25M of issuer financing - Stock Titan

Vaxart Files Preliminary Proxy Statement and Issues Open Letter to Shareholders - GlobeNewswire

[EFFECT] Vaxart, Inc. SEC Filing - Stock Titan

[S-1/A] Vaxart, Inc. Amends IPO Registration Statement - Stock Titan

Vaxart (VXRT) Institutional Ownership 2026 $VXRT - MarketBeat

Complete Defense Verdict in Rare Securities Class Action Trial - Cornerstone Research

MSN Money - MSN

Vaxart anticipates early 2027 primary efficacy readout while aiming for Q2 sentinel data release - MSN

Earnings call transcript: Vaxart’s mixed Q1 2026 results, EPS beats forecast - Investing.com India

Vaxart (VXRT) Reports Progress in Clinical Programs and Financia - GuruFocus

VXRT: Revenue surged and net income turned positive as clinical milestones and funding flexibility advanced - TradingView

Earnings call transcript: Vaxart’s mixed Q1 2026 results, EPS beats forecast By Investing.com - Investing.com South Africa

VXRT: Revenue doubled year-over-year, with clinical milestones and cash runway into Q2 2027 - TradingView

[S-1] Vaxart, Inc. Files IPO Registration Statement - Stock Titan

Vaxart Q1 2026 Earnings Call Transcript - MarketBeat

Vaxart : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com

VXRT: Returned to profitability in Q1 2026 with strong revenue growth and improved cash position - TradingView

Vaxart targets Q2 data from 400-person oral COVID vaccine study - Stock Titan

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results - The Manila Times

Vaxart, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

Vaxart (OTCQX: VXRT) swings to Q1 2026 profit on BARDA and collaboration revenue - Stock Titan

Vaxart (OTCQX: VXRT) swings to Q1 2026 profit as COVID trial advances - Stock Titan

Vaxart (VXRT) files ATM supplement to raise up to $49.8M via Sales Agents - Stock Titan

Finanzdaten der Vaxart Inc-Aktie (VXRT)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie VXRT